A retrospective cohort study published in 2024 analyzed how frequently ENT specialists prescribed ginkgo biloba extract, systemic corticosteroids or pentoxifylline to patients with newly diagnosed tinnitus. The analysis was based on a data set of electronically recorded medical records of over 100,000 patients from a heterogeneous population in eight regions of Germany.
Publikation
- HAUSARZT PRAXIS
- PHYTOTHERAPIE PRAXIS
Related Topics
You May Also Like
- Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib
First-class immunomodulation combined with convenience—the data available so far is convincing
- Preclinical Study on a Special Ginkgo biloba Extract
What role do proanthocyanidins play?
- Myasthenia gravis: immunomodulatory therapies for long-term treatment
Expanded Possibilities Thanks to Innovative Classes of Active Ingredients
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Interstitial Lung Diseases
Update on Idiopathic Pulmonary Fibrosis
- Ischemic stroke: Are smaller or larger brain arteries affected?
Recent study findings on intravenous lysis therapy with fibrinolytic agents
- Interview
“On par with the gold standards for trauma”
- Psychology: Emotional Freedom Techniques (EFT)